These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 20339095

  • 1. Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells.
    Liang X, Moseman EA, Farrar MA, Bachanova V, Weisdorf DJ, Blazar BR, Chen W.
    Blood; 2010 Jun 17; 115(24):5041-52. PubMed ID: 20339095
    [Abstract] [Full Text] [Related]

  • 2. Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells.
    Jahrsdörfer B, Wooldridge JE, Blackwell SE, Taylor CM, Griffith TS, Link BK, Weiner GJ.
    J Leukoc Biol; 2005 Mar 17; 77(3):378-87. PubMed ID: 15582984
    [Abstract] [Full Text] [Related]

  • 3. Toll-like receptor agonists induce apoptosis in mouse B-cell lymphoma cells by altering NF-κB activation.
    Arunkumar N, Liu C, Hang H, Song W.
    Cell Mol Immunol; 2013 Jul 17; 10(4):360-72. PubMed ID: 23727784
    [Abstract] [Full Text] [Related]

  • 4. CpG oligodeoxynucleotide CpG-685 upregulates functional interleukin-21 receptor on chronic lymphocytic leukemia B cells through an NF-κB mediated pathway.
    Browning RL, Mo X, Muthusamy N, Byrd JC.
    Oncotarget; 2015 Jun 30; 6(18):15931-9. PubMed ID: 26158860
    [Abstract] [Full Text] [Related]

  • 5. Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: costimulation with IL-2 results in a highly immunogenic phenotype.
    Decker T, Schneller F, Kronschnabl M, Dechow T, Lipford GB, Wagner H, Peschel C.
    Exp Hematol; 2000 May 30; 28(5):558-68. PubMed ID: 10812246
    [Abstract] [Full Text] [Related]

  • 6. Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells.
    Decker T, Schneller F, Sparwasser T, Tretter T, Lipford GB, Wagner H, Peschel C.
    Blood; 2000 Feb 01; 95(3):999-1006. PubMed ID: 10648415
    [Abstract] [Full Text] [Related]

  • 7. TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target.
    Kennedy E, Coulter E, Halliwell E, Profitos-Peleja N, Walsby E, Clark B, Phillips EH, Burley TA, Mitchell S, Devereux S, Fegan CD, Jones CI, Johnston R, Chevassut T, Schulz R, Seiffert M, Agathanggelou A, Oldreive C, Davies N, Stankovic T, Liloglou T, Pepper C, Pepper AGS.
    Blood; 2021 Jun 03; 137(22):3064-3078. PubMed ID: 33512408
    [Abstract] [Full Text] [Related]

  • 8. Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine.
    Wolska A, Cebula-Obrzut B, Smolewski P, Robak T.
    Leuk Lymphoma; 2013 Jun 03; 54(6):1268-78. PubMed ID: 23078646
    [Abstract] [Full Text] [Related]

  • 9. Sensitization of B-cell chronic lymphocytic leukemia cells to recombinant immunotoxin by immunostimulatory phosphorothioate oligodeoxynucleotides.
    Decker T, Hipp S, Kreitman RJ, Pastan I, Peschel C, Licht T.
    Blood; 2002 Feb 15; 99(4):1320-6. PubMed ID: 11830482
    [Abstract] [Full Text] [Related]

  • 10. B-CLL cells acquire APC- and CTL-like phenotypic characteristics after stimulation with CpG ODN and IL-21.
    Hagn M, Blackwell SE, Beyer T, Ebel V, Fabricius D, Lindner S, Stilgenbauer S, Simmet T, Tam C, Neeson P, Trapani JA, Schrezenmeier H, Weiner GJ, Jahrsdörfer B.
    Int Immunol; 2014 Jul 15; 26(7):383-95. PubMed ID: 24497611
    [Abstract] [Full Text] [Related]

  • 11. Dichotomy in NF-kappaB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering.
    Tromp JM, Tonino SH, Elias JA, Jaspers A, Luijks DM, Kater AP, van Lier RA, van Oers MH, Eldering E.
    Oncogene; 2010 Sep 09; 29(36):5071-82. PubMed ID: 20581863
    [Abstract] [Full Text] [Related]

  • 12. Ras participates in CpG oligodeoxynucleotide signaling through association with toll-like receptor 9 and promotion of interleukin-1 receptor-associated kinase/tumor necrosis factor receptor-associated factor 6 complex formation in macrophages.
    Xu H, An H, Yu Y, Zhang M, Qi R, Cao X.
    J Biol Chem; 2003 Sep 19; 278(38):36334-40. PubMed ID: 12867418
    [Abstract] [Full Text] [Related]

  • 13. The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease.
    Longo PG, Laurenti L, Gobessi S, Petlickovski A, Pelosi M, Chiusolo P, Sica S, Leone G, Efremov DG.
    Leukemia; 2007 Jan 19; 21(1):110-20. PubMed ID: 17024114
    [Abstract] [Full Text] [Related]

  • 14. CpG stimulation of chronic lymphocytic leukemia cells induces a polarized cell shape and promotes migration in vitro and in vivo.
    Dampmann M, Görgens A, Möllmann M, Murke F, Dührsen U, Giebel B, Dürig J.
    PLoS One; 2020 Jan 19; 15(2):e0228674. PubMed ID: 32040489
    [Abstract] [Full Text] [Related]

  • 15. Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21.
    Lai CY, Yu GY, Luo Y, Xiang R, Chuang TH.
    Front Immunol; 2019 Jan 19; 10():179. PubMed ID: 30800129
    [Abstract] [Full Text] [Related]

  • 16. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.
    Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdörfer B, Giese T, Endres S, Hartmann G.
    J Immunol; 2002 May 01; 168(9):4531-7. PubMed ID: 11970999
    [Abstract] [Full Text] [Related]

  • 17. Thymidine-phosphorothioate oligonucleotides induce activation and apoptosis of CLL cells independently of CpG motifs or BCL-2 gene interference.
    Castro JE, Prada CE, Aguillon RA, Kitada S, Fukuda T, Motta M, Wu C, Dicker F, Sun G, Wang JY, Carson DA, Reed JC, Kipps TJ.
    Leukemia; 2006 Apr 01; 20(4):680-8. PubMed ID: 16498393
    [Abstract] [Full Text] [Related]

  • 18. TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells.
    Mongini PK, Gupta R, Boyle E, Nieto J, Lee H, Stein J, Bandovic J, Stankovic T, Barrientos J, Kolitz JE, Allen SL, Rai K, Chu CC, Chiorazzi N.
    J Immunol; 2015 Aug 01; 195(3):901-23. PubMed ID: 26136429
    [Abstract] [Full Text] [Related]

  • 19. Expression of Toll-like receptor9 in diffuse large B-cell lymphoma: further exploring CpG oligodeoxynucleotide in NFκB pathway.
    Huang WT, Weng SW, Huang CC, Lin HC, Tsai PC, Chuang JH.
    APMIS; 2012 Nov 01; 120(11):872-81. PubMed ID: 23009111
    [Abstract] [Full Text] [Related]

  • 20. A threshold level of TLR9 mRNA predicts cellular responsiveness to CpG-ODN in haematological and non-haematological tumour cell lines.
    Assaf A, Esteves H, Curnow SJ, Browning MJ.
    Cell Immunol; 2009 Nov 01; 259(1):90-9. PubMed ID: 19573862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.